Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies

AIDS

Volumn 17, Issue 15, 2003, Pages 2169-2176

  Fiore, Josè Ramòn ^a   Suligoi, Barbara ^b   Saracino, Annalisa ^c   Di Stefano, Mariantonietta ^c   Bugarini, Roberto ^b   Lepera, Achiropita ^a   Favia, Anna ^a   Monno, Laura ^a   Angarano, Gioacchino ^c   Pastore, Giuseppe ^a  

^a UNIVERSITY OF BARI   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Antiretroviral; Genital secretions; HIV; Sexual transmission; Viral shedding

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; CANDIDA; CELL FREE SYSTEM; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MYCOPLASMA; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; PLASMA; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SIDE EFFECT; T LYMPHOCYTE; TREATMENT OUTCOME; UTERINE CERVIX CYTOLOGY; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CERVIX UTERI; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; RISK FACTORS; RNA, VIRAL; VAGINA; VIRAL LOAD; VIRUS SHEDDING;

EID: 10744231331     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200310170-00004     Document Type: Article

References (22)

1. Quinn TC. Global burden of the HIV pandemic. Lancet 1996, 348:99-106.
2. Work group on mother-to-child transmission of HIV. Rates of mother-to-child transmission in Africa, America and Europe: results from 13 perinatal studies. J Acquir Immune Def Syndr Hum Retrovirol 1995, 8:506-510.
3. Mostad SB, Kreiss JK. Shedding of HIV in the genital tract. AIDS 1996, 10:1305-1315.
4. Wang CC, McClelland RR, Reilly MB, Overbaugh J, Emery SR, Mandaliya K, et al. The effect of treatment of vaginal infections on shedding of Human Immunodeficiency Virus Type 1. J Infect Dis 2001, 183:1017-1022.
5. Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CC, et al. Association between bacterial vaginosis and expression of Human Immunodeficiency Virus type 1 RNA female genital tract. Clin Infect Dis 2001, 33:894-896.
6. Mostad SB, Overbaugh S, De Vange DM, Welch MJ, Chohan B, Mandaliya K, et al. Hormonal contraception, vitamin A deficiency and other risk factors for shedding of HIV infected cells from the cervix and vagina. Lancet 1997, 350:922-927.
7. Clemetson DB, Moss JB, Willerford DM, Hensel M, Emonyi W, Holmes KK, et al. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA 1993, 269:2860-2864.
8. Kovacs A, Chan LS, Chen ZC, Meyer WA 3rd, Muderspach L, Young M, et al. HIV-1 RNA in plasma and genital secretions in women infected with HIV-1. J AIDS 1999, 22:124-131.
9. Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS 2000, 14:415-421.
10. Kovacs A, Wasserman SS, Burns D, Wright DJ, Cohn J, Landay A, et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001, 358:1593-1601
11. Mohamed AS, Becquart P, Hocini H, Metais P, Kazatchkine M, Belec L. Dilution assessment of cervicovaginal secretions collected by vaginal washing to evaluate mucosal shedding of free Human Immunodeficiency Virus. Clin Diagn Lab Immunol 1997, 4:624-626.
12. Mostad SB. Prevalence and correlates of HIV type 1 shedding in the female genital tract. AIDS Res Hum Retroviruses 1998, 14 (suppl. 1):S11-S15.
13. Leroy V, Montcho C, Manigart O, Van de Perre P, Dabis F, Msellati P, et al. Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa DITRAME ANRS 049a trial. AIDS 2001, 15:517-522.
14. Pedraza MA, Del Romero J, Roldan F, Garcia S, Acerbe MC, Noriega AR, et al. Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation of the infected partner. J AIDS 1999, 21:120-125.
15. Musicco M, Lazzarin A, Nicolosi A, Gasparini M, Costigliola P, Arici C, et al. Antiretroviral treatment of men infected with HIV-1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV heterosexual transmission. Arch Intern Med 1994, 154:1971-1976.
16. Nicolosi A, Musicco M, Saracco A, Lazzarin A. Risk factors for woman-to-man sexual transmission of HIV. Italian Study Group on HIV heterosexual transmission. J AIDS 1994, 7:296-300.
17. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1 infected women and prevention of perinatal HIV-1 transmission. J AIDS 2002, 29:484-494.
18. Ioannidis JP, Abrams EJ, Ammann A, Bulterys M, Goedert JJ, Gray L, et al. Perinatal transmission of HIV-1 by pregnant women with RNA virus loads < 1000 copies/ml. J Infect Dis 2001, 183: 539-545.
19. Saracino A, Di Stefano M, Vimercati A, Greco P, Fiore JR, Monno L, et al. Cervicovaginal HIV-1 shedding in pregnant women near delivery. Antiviral Ther 2001, 6:79-81.
20. Lawn SD, Subbarao S, Wright TC Jr, Evans-Strickfaden T, Ellerbrock TV, Lennox JL, et al. Correlation between human immunodeficiency virus type-1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. J Infect Dis 2000, 181:1950-1956.
21. Cohn MA, Frankel SS, Rugpao S, Young MA, Willett C, Tovanabutra S, et al. Chronic inflammation with increased human immunodeficiency virus (HIV) RNA expression in the vaginal epithelium of HIV-infected Thai women. J Infect Dis 2001, 184:410-417.
22. Rotchford K, Strum AW, Wilkinson D. Effect of coinfection with STD and of STD treatment on HIV shedding in genital secretions: systematic review and data synthesis. Sex Transm Dis 2000, 27:243-248.